These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6724478)

  • 1. [Mechanism of action of dydrogesterone in dysmehorrhea. Prostaglandin levels in menstrual blood].
    Zahradnik HP
    Fortschr Med; 1984 Apr; 102(15):439-42. PubMed ID: 6724478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects of pathogenesis and treatment of dysmenorrhoea (author's transl)].
    Zahradnik HP; Stengele E; Kraut E; Breckwoldt M
    Dtsch Med Wochenschr; 1978 Aug; 103(33):1298-30. PubMed ID: 679824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid.
    Chan WY; Dawood MY; Fuchs F
    Am J Obstet Gynecol; 1979 Sep; 135(1):102-8. PubMed ID: 474640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of progesterone uterine therapeutic system on dysmenorrhoea: prostaglandin F2alpha levels in menstrual blood (author's transl)].
    Zahradnik HP; Stengele E; Kraut E; Scharpf G; Breckwoldt M
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1270-3. PubMed ID: 668582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY; Fuchs F; Powell AM
    Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
    Strecker JR
    Fortschr Med; 1980 Jan; 98(4):(145-7). PubMed ID: 7189174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uterine prostaglandins and dysmenorrhea].
    Seifert B; Liedtke MP
    Zentralbl Gynakol; 1978; 100(21):1361-6. PubMed ID: 735539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea.
    Dawood MY; Khan-Dawood FS
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):146-53. PubMed ID: 17259081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of prostaglandins in the regulation of cyclic events in the ovary and uterus.
    Lindner HR; Zor U; Kohen F; Bauminger S; Amsterdam A; Lahav M; Salomon Y
    Adv Prostaglandin Thromboxane Res; 1980; 8():1371-90. PubMed ID: 7376986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea.
    Strömberg P; Forsling ML; Akerlund M
    Obstet Gynecol; 1981 Aug; 58(2):206-8. PubMed ID: 7254732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E; von Fischer B
    Adv Prostaglandin Thromboxane Res; 1980; 8():1487-93. PubMed ID: 6769316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study.
    Taniguchi F; Ota I; Iba Y; Toda T; Tagashira Y; Ohata Y; Kurioka H; Endo Y; Sunada H; Noma H; Azuma Y; Harada T
    J Obstet Gynaecol Res; 2019 Jan; 45(1):168-175. PubMed ID: 30246276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of dydrogesterone in postpubertal menstruation disorders].
    Tabaste JL; Servaud M; Steiner E; Dabir P; Bene B; Pouzet M
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):19-20, 23-5. PubMed ID: 6531584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnesium--a new therapeutic alternative in primary dysmenorrhea].
    Seifert B; Wagler P; Dartsch S; Schmidt U; Nieder J
    Zentralbl Gynakol; 1989; 111(11):755-60. PubMed ID: 2675496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
    Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostaglandins and benign mastopathies (author's transl)].
    Rolland PH; Martin PM; Bourry M; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(3):197-201. PubMed ID: 7264251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary dysmenorrhea: current insights in etiology and treatment].
    Hein PR; Eskes TK
    Ned Tijdschr Geneeskd; 1984 Jan; 128(2):73-8. PubMed ID: 6422313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dydrogesterone (Gynorest and Duphaston).
    Med Lett Drugs Ther; 1969 Apr; 11(7):31-2. PubMed ID: 5781648
    [No Abstract]   [Full Text] [Related]  

  • 19. Zinc treatment prevents dysmenorrhea.
    Eby GA
    Med Hypotheses; 2007; 69(2):297-301. PubMed ID: 17289285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.
    Dawood MY
    Drugs; 1981 Jul; 22(1):42-56. PubMed ID: 6790261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.